Bryce Chackerian

6.4k total citations
87 papers, 4.2k citations indexed

About

Bryce Chackerian is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Bryce Chackerian has authored 87 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 29 papers in Epidemiology and 28 papers in Molecular Biology. Recurrent topics in Bryce Chackerian's work include Monoclonal and Polyclonal Antibodies Research (22 papers), HIV Research and Treatment (22 papers) and Bacteriophages and microbial interactions (22 papers). Bryce Chackerian is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (22 papers), HIV Research and Treatment (22 papers) and Bacteriophages and microbial interactions (22 papers). Bryce Chackerian collaborates with scholars based in United States, Panama and Australia. Bryce Chackerian's co-authors include David S. Peabody, John T. Schiller, Julie Overbaugh, Douglas R. Lowy, Julianne Peabody, Ebenezer Tumban, E. Michelle Long, Lyle M. Rudensey, Kathryn M. Frietze and Paul A. Luciw and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Bryce Chackerian

83 papers receiving 4.1k citations

Peers

Countries citing papers authored by Bryce Chackerian

Since Specialization

Citations

This map shows the geographic impact of Bryce Chackerian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryce Chackerian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryce Chackerian more than expected).

Fields of papers citing papers by Bryce Chackerian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryce Chackerian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryce Chackerian. The network helps show where Bryce Chackerian may publish in the future.

Co-authorship network of co-authors of Bryce Chackerian

This figure shows the co-authorship network connecting the top 25 collaborators of Bryce Chackerian. A scholar is included among the top collaborators of Bryce Chackerian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryce Chackerian. Bryce Chackerian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl 2025 ·npj Vaccines ·(unknown), (unknown), (unknown), (unknown), Marcus F. Brackeen, Bruce E. Blough, Subhakar Dey, Yumei Huang, Herman F. Staats, William C. Wetsel, Bryce Chackerian, Kathryn M. Frietze	0
2	An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens 2024 ·The Journal of Immunology ·(unknown), (unknown), (unknown), James L. Mueller, (unknown), Bryce Chackerian, Julie Zikherman, Wei Cheng	2
3	A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood 2023 ·Vaccine ·(unknown), (unknown), Naomi Lee, (unknown), Koen K. A. Van Rompay, Yumei Huang, Bryce Chackerian, Kathryn M. Frietze	3
4	A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates 2023 ·npj Vaccines ·(unknown), Koen K. A. Van Rompay, Maureen Sampson, (unknown), Jennifer Watanabe, (unknown), (unknown), Debbie M. Lovato, John T. Schiller, Alan T. Remaley, Bryce Chackerian	19
5	A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice 2021 ·Vaccine ·(unknown), Maureen Sampson, Alan T. Remaley, Bryce Chackerian	16
6	An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein 2021 ·npj Vaccines ·(unknown), (unknown), (unknown), Nikolai Petrovsky, Fidel Zavala, Bryce Chackerian	32
7	Engineering an Antibody V Gene-Selective Vaccine 2021 ·Frontiers in Immunology ·Larance Ronsard, Ashraf S. Yousif, Julianne Peabody, (unknown), Pascal Devant, (unknown), Ralston M. Barnes, Daniel Rohrer, Nils Lönberg, David S. Peabody, Bryce Chackerian, Daniel Lingwood	4
8	Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide 2020 ·Vaccines ·(unknown), Lihong Liu, (unknown), (unknown), Kai Xu, Rui Kong, Jing Huang, Jian Yu, Peter D. Kwong, John R. Mascola, David D. Ho, Moriya Tsuji, Bryce Chackerian	15
9	Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus 2019 ·Immunity ·Maya Sangesland, Larance Ronsard, Samuel W. Kazer, Julia Bals, Seyhan Boyoglu-Barnum, Ashraf S. Yousif, Ralston M. Barnes, Jared Feldman, (unknown), Patrick M. McTamney, Daniel Rohrer, Nils Lönberg, Bryce Chackerian, Barney S. Graham, Masaru Kanekiyo, Alex K. Shalek, Daniel Lingwood	57
10	A VACCINE-BASED STRATEGY FOR REDUCING CARDIOVASCULAR DISEASE RISK FACTORS 2017 ·Journal of the American College of Cardiology ·Ingrid Lindquist, (unknown), Marcelo Amar, Alan T. Remaley, Bryce Chackerian	4
11	Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence–Coupled Biopanning Platform 2015 ·Cancer Immunology Research ·Kathryn M. Frietze, Richard B.S. Roden, Ji‐Hyun Lee, Yang Shi, David S. Peabody, Bryce Chackerian	21
12	Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform 2015 ·Current Opinion in Virology ·John P. O’Rourke, David S. Peabody, Bryce Chackerian	22
13	Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display 2015 ·PLoS ONE ·(unknown), Kathryn M. Frietze, David L. Narum, David S. Peabody, Bryce Chackerian	14
14	A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein 2014 ·Malaria Journal ·Rosalynn Ord, Jerri C. Caldeira, Marilis Rodriguez, Amy R. Noe, Bryce Chackerian, David S. Peabody, Gabriel M. Gutierrez, Cheryl A. Lobo	44
15	Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway 2014 ·PLoS ONE ·John P. O’Rourke, Seth M. Daly, Kathleen D. Triplett, David S. Peabody, Bryce Chackerian, Pamela R. Hall	23
16	Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses 2011 ·Vaccine ·Zoe Hunter, Ebenezer Tumban, (unknown), Bryce Chackerian	14
17	Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model 2008 ·The Journal of Immunology ·Bryce Chackerian, (unknown), John T. Schiller	77
18	Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice 2004 ·BMC Neuroscience ·Qingyou Li, Chuanhai Cao, Bryce Chackerian, John T. Schiller, Marcia N. Gordon, Kenneth E. Ugen, Dave Morgan	43
19	Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles 2002 ·The Journal of Immunology ·Bryce Chackerian, Petra H. Lenz, Douglas R. Lowy, John T. Schiller	148
20	Characterization of a CD4-Expressing Macaque Cell Line That Can Detect Virus after a Single Replication Cycle and Can Be Infected by Diverse Simian Immunodeficiency Virus Isolates 1995 ·Virology ·Bryce Chackerian, Nancy L. Haigwood, Julie Overbaugh	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact